Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $805,500 | $773,400 | $610,600 | $501,800 |
| % Growth | 4.2% | 26.7% | 21.7% | – |
| Cost of Goods Sold | $440,400 | $393,500 | $306,700 | $247,200 |
| Gross Profit | $365,100 | $379,900 | $303,900 | $254,600 |
| % Margin | 45.3% | 49.1% | 49.8% | 50.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $202,300 | $244,500 | $208,000 | $168,600 |
| Sales & Mktg Exp. | $0 | $0 | $208,000 | $168,600 |
| Other Operating Expenses | $53,800 | $70,700 | $62,300 | $66,000 |
| Operating Expenses | $256,100 | $315,200 | $270,300 | $234,600 |
| Operating Income | $109,000 | $61,900 | $24,600 | $21,600 |
| % Margin | 13.5% | 8% | 4% | 4.3% |
| Other Income/Exp. Net | -$245,600 | -$29,500 | -$31,200 | -$50,000 |
| Pre-Tax Income | -$136,600 | $14,100 | -$13,600 | -$28,400 |
| Tax Expense | -$6,200 | $4,200 | $900 | $100 |
| Net Income | -$130,400 | $9,900 | -$14,500 | -$28,500 |
| % Margin | -16.2% | 1.3% | -2.4% | -5.7% |
| EPS | -0.74 | 0.058 | -0.087 | -0.17 |
| % Growth | -1,387% | 165.8% | 48.6% | – |
| EPS Diluted | -0.74 | 0.058 | -0.087 | -0.17 |
| Weighted Avg Shares Out | 176,294 | 168,662 | 165,835 | 164,258 |
| Weighted Avg Shares Out Dil | 176,294 | 172,065 | 165,835 | 164,258 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $20,600 | $21,700 | $22,200 | $21,200 |
| Depreciation & Amortization | -$136,700 | $70,700 | $62,300 | $66,000 |
| EBITDA | -$27,700 | $132,600 | $86,900 | $81,600 |
| % Margin | -3.4% | 17.1% | 14.2% | 16.3% |